Faslodexhcp.com has yet to be estimated by Alexa in terms of traffic and rank. Moreover, Faslodexhcp is slightly inactive on social media. There is still a lack of data on safety and reputation of this domain, so you should be very careful when browsing it.
Popular pages to visit on faslodexhcp.com
Estrogen Receptor Antagonist | FASLODEX® (fulvestrant) Injection Mechanism of Action
Learn about the mechanism of action of FASLODEX® (fulvestrant) Injection, an estrogen receptor antagonist.
CONFIRM Trial and Patient Population | FASLODEX® (fulvestrant) Injection
Review data from the CONFIRM trial, a controlled study of FASLODEX® (fulvestrant) Injection 500 mg and FASLODEX® (fulvestrant) Injection 250 mg.
FASLODEX® (fulvestrant) Injection 500 mg in Summary
Read about FASLODEX® (fulvestrant) Injection 500 mg, prescribed by physicians to treat HR-positive metastatic breast cancer in postmenopausal women after antiestrogen therapy.
Domain info
Location: | United States |
Owned by: | Domains Administration (AstraZeneca AB) |
Hosted by: | Corporation Service Company |
Registered by: | CSC Corporate Domains, Inc. |
Subnetworks: | 99.84.110.12, 99.84.110.66, 99.84.110.98, 99.84.110.129 |
More domains registered by CSC Corporate Domains, Inc.
Social Networks Activity
Facebook likes: | - |
Twitter mentions: | - |
Google pluses: | - |
LinkedIn mentions: | - |
Pinterest pins: | - |
StumbleUpon views: | - |